Table 3. Quality of stroke care among women with ischemic stroke patients covered by the URBMI/UEBMI and NRCMS.
Performance measures | Total, N (%) | URBMI/UEBMI, N (%) | NRCMS, N (%) | P value |
---|---|---|---|---|
IV rt-PA within 2 hours | 56 (16.2) | 32 (16.8) | 24 (15.4) | 0.7138 |
Early antithrombotics | 4,677 (84.4) | 2,323 (83.2) | 2,354 (85.6) | 0.0152 |
Discharge antithrombotics | 4,664 (89.8) | 2,326 (88.2) | 2,338 (91.4) | 0.0002 |
Anticoagulation for atrial fibrillation/flutter | 131(22.3) | 70 (21.0) | 61 (24.0) | 0.3888 |
LDL ≥100 or not documented | 2,730 (67.3) | 1,336 (63.4) | 1,394 (71.6) | <0.0001 |
Antihypertension for hypertension disease | 3,031 (66.3) | 1,576 (67.8) | 1,455 (64.8) | 0.0286 |
Hypoglycemic therapy for diabetes mellitus | 1,369 (75.4) | 780 (76.3) | 589 (74.3) | 0.3158 |
IV rt-PA, intravenous recombinant tissue-type plasminogen activator; LDL, low-density lipoprotein; NRCMS, New Rural Cooperative Medical Scheme; URBMI/UEBMI, urban resident/employee basic medical insurance.